INTRODUCTION
Anti-cholesterol antibodies (ACHAs) naturally occur in the sera of most healthy individuals with yet unknown functions (1) . Recently we reported on new IgG type monoclonal antibodies, AC1 and AC8, which are highly specific to clustered cholesterol and some 3β-OH-containing sterols and do not cross-react with other lipids (2) . These antibodies, in contrast to the IgM type ACHAs reported earlier, have a unique property of spontaneous binding to live phagocytes and T cells. Furthermore, their binding to the cell surface was substantially sensitive to the epitope accessibility, e.g. it was greatly enhanced by limited papain digestion of membrane proteins with long extracellular domains. Their spontaneous binding to intact cells also showed cell-type dependence.
The preferential binding sites for these new cholesterol-specific mAbs were identified as cell surface or intracellular membrane compartments enriched in clustered cholesterol, such as lipid rafts, caveolas or Golgi complexes (2) .
Lipid rafts are dynamic, glycosphingolipid-and cholesterol-rich membrane microdomains considered to make 'some order into the chaos' of biological membranes (3, 4). Many pieces of experimental evidence indicate that the human immunodeficiency virus type 1, HIV-1, enters target cells through these lipid rafts (5-7). The last stage of the multi-step process of HIV-1 entry, the fusion of the virus with the target cell membrane, entails multifocal interactions between virus shell glycoproteins and lipids and their receptor/co-receptor and lipid raft counterparts on target cells (8). Lipid rafts were also implicated in the budding of the progeny virus (9, 10).
HIV-1 was shown to use the CD4 receptor and CCR5, or CXCR4 chemokine receptors for productive entry into CD4 + cells. CD4 and CCR5 are constitutively raftby guest, on October 22, 2017 www.jlr.org Downloaded from associated, while CXCR4 molecules are mostly recruited to lipid rafts after the initial binding of the virus (11). However, the exact molecular mechanism of this entry is still on debate (9, 12). Since the new cholesterol-specific mAbs selectively bind to cholesterol-enriched lipid raft or caveola microdomains of intact HIV-1 permissive cells, it is plausible to assume that they may interfere somehow with the mechanisms leading to membrane attachment or internalization of the virus.
Therefore, the present study aimed to investigate whether the new ACHAs can modulate the receptor or microdomain architecture at the surface of target cells, such as human macrophages and T cells. Namely the distribution/interaction pattern, accessibility, internalization, mobility or raft association of CD4 and chemokine receptors. These properties are all critical for membrane attachment and internalization of the virus.
Since in a recent work (13) another anti-lipid antibody, a mAb against phosphatidylinositol-4-phosphate (PIP), was reported to inhibit infection of peripheral blood mononuclear cells (PBMCs) with two HIV-1 primary isolates, we also investigated whether the new cholesterol-specific antibodies can affect in vitro HIV-1 infection/production of primary monocyte-derived macrophages (MDM) and T cells in cultures.
The new IgG type cholesterol-specific antibodies caused a remarkable lateral clustering of membrane rafts upon binding to both cell types and remodeled the interaction pattern of CXCR4 chemokine receptors with both CD4 and lipid rafts. The membrane-bound antibodies substantially inhibited production of two different HIV strains in MDM and T cells, in vitro. In contrast, no significant inhibition was achieved 
MATERIALS AND METHODS

Cells, immunofluorescence labeling and flow cytometry
The monoclonal IgG 3 Abs to cholesterol, AC1 and AC8, were generated, characterized and applied for cell labeling as described previously (2) . Cell surface binding of Alexa488-ACHA, PE/Cy5-anti-CD4 (ImmunoTools, Friesoythe, Germany) or APC-anti-CXCR4 (R&D Systems, Minneapolis, MN) was assayed by flow cytometry.
After FcR-blocking with affinity purified human IgG 1 , cells were washed with FACS buffer containing 0.1% BSA, then stained as described elsewhere (2) . Occasionally, prior to receptor staining, U937 human macrophages (ATTC, maintained in RPMI 1640 medium + 10% FBS) and MT-4 T-cells were preincubated with ACHA or the Ka40 isotype control Ab (specific to tobacco mosaic virus) at 37 o C for 60 min.
In the CXCR4 receptor internalization assay, U937 cells were incubated (or not)
with ACHA as described above. After washing, cells were treated with 300 nM SDF-1α chemokine ligand or, alternatively, with 100 ng/ml of the phorbol ester PMA, at 37 o C, for 0-60 min. Cells were then washed, FcR-blocked and labeled with APC-anti-CXCR4 as described above. Before measurement, cells were fixed with 3%
paraformaldehyde. CXCR4 expression on the cell surface was measured and evaluated by flow cytometry.
Data from 10,000 stained cells/sample were acquired in a Becton-Dickinson FACSCalibur flow cytometer, using the CellQuest Pro software (Becton-Dickinson, San
Jose, CA), and then analyzed with FCS3 Express software (De Novo Software, Los
Angeles, CA).
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Surface plasmon resonance (SPR)
SPR measurements were performed using a BIACORE X instrument (Biacore, Uppsala, Sweden), at 25°C. AC8 ACHA and anti-CD8 control IgG (30 µg/ml) were immobilized onto the surface of a carboxymethylated dextran chip (CM5) using standard amine-coupling chemistry in 10 mM sodium acetate, pH 5.0, according to the manufacturer's instructions. The mean amount of immobilized protein was ~7000 RU (resonance unit). Cholesterol-rich (1,2-dimiristoyl-sn-glycero-3-phosphocholine, 1,2 dimiristoyl-sn-3-phosphoglyerol and cholesterol, in a 9:1:25 molar ratio) and cholesterolfree control liposomes were prepared as described earlier (2), reconstituted in 10 mM HEPES, pH 7.2, 150 mM NaCl solution (running buffer) at a concentration of 1 mM total lipid, and were passed over the chip surface at a flow rate of 10 µl/min. The results were analysed by BIAevaluation 4.1 software (Biacore). The corresponding association and dissociation regimes of sensorgrams were fitted to a built-in Langmuir binding model and the equilibrium dissociation constant, K D , was calculated as the ratio of dissociation to association rate constants.
Confocal microscopy
U937 human macrophages were treated with AC8 (or Ka40 isotype control) antibodies as described above and, as a negative control to raft-associated proteins, with 
where N is the average number of molecules in the detection volume, T is the fraction of dyes being in the triplet state within the detection volume, τ tr is the phosphorescence lifetime and τ d is the diffusion time, which is the average time spent by the dye in the detection volume. The half-decay time τ 1/2 was used to determine the average diffusion coefficients, as described earlier (18) .
Target cells and HIV-1 strains
HIV-1 IIIB permissive H9 cell line (for virus propagation) and MT-4 T cells (ATCC) were maintained in completed RPMI 1640 medium (cRPMI: 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, and 1 mM L-glutamine; Gibco BRL, Gaithersburg, MD). The primary MDM cells were separated from peripheral blood mononuclear cells of healthy, HIV-1 seronegative donors using PHA stimulation as described earlier (19) . The MDM cultures were used for HIV-1 infection in all experiments on day 7 after separation. 
Measurement of anti-cholesterol antibodies in cell culture supernatants by ELISA.
Concentration of anti-cholesterol antibodies in cell culture supernatants was measured by the ELISA method as described previously (2).
Statistical analysis
Diffusion coefficients in control and ACHA-treated cells were compared using Student's t-test (the number of individual cells for each sample is given in Table 1 ). These data, completing recent semiquantitative results showing low/medium affinity ACHA binding to isolated membrane raft fractions of T cells (2) , suggest that the optimal affinity of ACHAs to 'clustered cholesterol' is medium, meanwhile the binding is highly selective.
Binding of AC8 does not alter the accessibility or internalization of HIV-1 receptors on target cells
Earlier we demonstrated the spontaneous binding of the new cholesterol-specific antibodies to several mouse and human lymphoid and myeloid cell types (2). Here we show that AC8 can also bind to HIV-1 permissive human MT-4 T cells and U937 macrophages (Fig. 1B) , the potential target cells of the IIIB and Ada-M HIV-1 strains,
respectively. In addition, AC8 does not mask the extracellular domains of CD4 or CXCR4 receptors on these cells, since the binding of antibodies against these epitopes remained unchanged after AC8 binding (Fig. 1C) .
The HIV-1 co-receptor CXCR4 was shown to rapidly internalize upon binding chemokine ligand SDF-1α or after PMA treatment and a mechanism involving the cytoskeleton and motor proteins (myosin IIa) was also proposed for this process (23) . It was supposed that internalization of the chemokine receptor may also influence HIV-1 interaction/entry to target cells. Therefore, the SDF-1 or PMA induced internalization of CXCR4 was also followed in context with the possible effects of the AC8 antibody.
Results with human U937 macrophage cells showed that the cholesterol-specific antibody AC8 does not significantly affect internalization of CXCR4 induced either by SDF-1 or PMA (Fig. 1D) . In contrast, the CD4-CTX-B colocalization was high (CI: >0.6), similarly to many other cell types (Fig. 3) . This indicates the lack of significant association between CD4 and CXCR4 on these target cells, and is also consistent with their localization in distinct membrane microdomains in the absence of the virus.
Binding of AC8 to the target cells' surface induces lateral lipid raft clustering
Binding of AC8 antibody to these cells caused an approximately two-fold increase of the colocalization between CXCR4 and CD4 as well as between CXCR4 and GM 1 -rafts, while leaving CD4-raft colocalization unchanged. Neither the engagement/cross-linking of a non-raft protein, the transferrin receptor (CD71) with its specific mAb, nor the isotype control antibody affected these colocalization patterns.
The monovalent Fab fragment of AC8 antibody, without cross-binding capacity, had no effect either on the colocalization between HIV-receptors (Fig. 4A) .
The increased proximity/interaction between CXCR4 and CD4 was further (Fig. 4B) .
The AC8 antibody selectively reduces the lateral mobility of CXCR4 but not that of CD4 In order to see whether AC8 has any influence on the molecular mobility of plasma membrane HIV-1 receptors, the diffusion properties of CXCR4 and CD4 were assessed by fluorescence correlation spectroscopic (FCS) imaging. AC8 binding to macrophages significantly reduced 2D diffusion of CXCR4 but not that of CD4 (Fig.   5A,B) . Diffusion of a non-raft protein, CD2, was not affected by ACHA treatment either in macrophages ( Fig. 5C ; Table 1 dose-dependent inhibition of virus production by both mAbs in both cell types relative to the control (untreated) cells (Fig. 6A,B) . The isotype control antibody left the infection unchanged (not shown).
Importantly, much less if any inhibition was observed when the virus strains were preincubated, at the same conditions, with the ACHAs prior to infection (Fig.   6C,D) .
ACHAs interfere mostly with the attachment phase of HIV-1 infection
To reveal with which stage of HIV-1 infection (attachment/entry/budding) the ACHAs interfere, we compared their inhibitory effects under different experimental conditions (concerning antibody treatment, infection, washing and culturing).
When ACHA was washed out from the sample after virus infection (see protocol 2 in Materials and Methods) the extent of inhibition remained the same as in case if it was not washed out from the culture after infection (Fig. 7A) . This indicates that the post-infection presence of ACHAs did not decrease the virus production further.
Since the level ACHAs in the culture medium gradually declines during the relatively long assay period (Fig. 7B) , we also tested if a continuous supplementation of ACHA after infection (see protocol 3 in Materials and Methods) can influence the observed inhibition. Such supplementation, however, did not result in any significant change in the final HIV-1 production (Fig.7B) , suggesting that the inhibitory effect is not coupled to inhibition of the later, budding phase. 
Monoclonal ACHAs are not cytotoxic to MT-4 T and MDM cells
Finally, it was tested if the observed inhibition is due to any significant cytotoxic effect of the anti-cholesterol mAbs exerted on the target cells. MT-4 cells and monocytederived macrophages were treated with serial dilutions of ACHAs and cultured for 4 and 14 days, respectively. ACHAs proved to be non-toxic to the investigated cell types, since their 'survival rate' remained above 90% over the whole experimental period (the cells retained both their metabolic activity and proliferation capacity) at any ACHA concentrations examined (Fig. 7C) .
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DISCUSSION
We report here the inhibition of HIV-1 infection/production of human monocytemacrophage and T cells by two new cholesterol-specific IgG antibodies, AC1 and AC8.
As a novel aspect, this study points out that anti-lipid antibodies may act effectively not only on the virus but also on the target cell membrane, in contrast to the principle considered earlier in context of most neutralizing antibodies (26, 27) . In the plasma membrane of the investigated cell types, CD4 is constitutively and highly, whereas CXCR4 is much more weakly raft-localized. Their localization and clustering in distinct membrane microdomains on HIV-1 permissive target cells was proposed earlier (30, 31) . Binding of the cholesterol-specific mAb (AC8), but not of its (25) . The size of the antibody label may partly be responsible for these differences. However, since the diffusion of membrane cholesterol is mostly controlled by the membrane environment rather than the extracellular aqeous phase (where the antibody is located), the slower diffusion also indicates that the AC8-cholesterol complexes diffuse in large, cholesterol-enriched microdomains.
In untreated control cells the HIV-1 receptor CD4 diffused slower than the nonraft membrane protein CD2 and the diffusional rate of CXCR4 was significantly higher than that of CD4. The lateral mobility of CXCR4 but not of CD4 decreased substantially upon AC8 binding. The selectivity of AC8 effect on CXCR4 mobility is also demonstrated by the unaffected mobility of CD2 non-raft protein on the same cells.
These data, and the similarity in diffusion coefficients of CD4 and CXCR4 after AC8
binding, are consistent with the the picture that AC8 colocalizes the chemokine receptor and CD4 into the same compartment.
Based on these substantial changes in the dynamic membrane organization of HIV-1 receptors, it is postulated that the AC8 mAb can 'mimic' the action of viral glycoprotein gp120 in terms of co-aggregating HIV-1 receptors and co-receptors, as proposed earlier (12). These data also concur with the findings that gp120-CD4 engagement leads to a cholesterol-sensitive lateral redistribution of membrane microdomains and a subsequent assembly of the virus internalization complex (6).
The novel cholesterol-specific antibodies preincubated with the target cells showed a significant and dose dependent inhibitory effect on HIV-1 infection. This inhibition might be dependent on cell type, the nature of the virus strain, and the assay conditions. The inhibitory effects of AC1 and AC8 cholesterol-specific antibodies on MDM and T cells were comparable to those previously reported for anti-PIP antibody exhibiting neutralizing activity and blocking infection of PBMC by two primary isolates of HIV-1, and to the well known broadly neutralizing 4E10 on PBMC (13).
Considering that washing out of ACHAs prior to (or after) infection or their continuous supplementation throughout culturing did not significantly affect the final by guest, on October 22, 2017 www.jlr.org
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HIV-1 production, we concluded that their inhibitory effect is mostly due to modulation of the attachment/entry phase. Although it is difficult to distinguish between these two possibilities based on the present data, the unchanged inhibition observed after immediate washing out of ACHAs after infection suggests that the most likely phase that is inhibited is the attachment/anchorage of the virus to the target cell surface.
Thus, the presented data unequivocally show that the ACHAs act predominantly on the target cell membrane. Furthermore, the inhibition was found not to be due to HLA class I and II, ICAM-1) involved in the entry process (37) seem to be equally important. Since, as detailed above, cholesterol also has a major role in these processes, cholesterol-specific antibodies may also merit consideration.
In conclusion, the new cholesterol-specific mAbs, AC1 and AC8, inhibit HIV-1 production of human T cells and macrophages by acting on the plasma membrane and HIV-1 receptors of target cells (Fig. 8) were incubated with different concentrations of monoclonal ACHAs (black columns for AC1 and white columns for AC8) or left untreated (grey columns) for 1 h, prior to virus infection (see protocol 1 in Materials and Methods). Virus production, measured by RT assay, is displayed in dpm units as mean ± SD (from 3 independent measurements). 
